ENA
23 października 2024
AACR-NCI-EORTC International Conference (ENA) 2024, October 23-25, 2024
Rok
2024
Cel
RVU120 (CDK8/CDK19), RVU 305 (PRMT5), ONCO Prime, Novel Targets, WRN
Zasoby na tej stronie
Pobierz zasoby
- plik pdf
Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors
Pobierz - plik pdf
Discovery of novel MTA-cooperative PRMT5 preclinical candidate as targeted therapeutics for MTAP-deleted cancers
Pobierz - plik pdf
Discovery of WRN inhibitors as targeted therapy in the treatment of microsatellite unstable (MSI-H) tumors
Pobierz - plik pdf
Exploring Synthetic Lethality and Novel Drug Combinations in Patient-Derived Cells
Pobierz